Capricor Therapeutics Inc

Healthcare · Biotechnology

8.10$ +4.5% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Capricor Therapeutics Inc (CAPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 369 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CAPR
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	24	19	14	14	16	16	15	14	12	9.2	8.6	7.3	7.9	11	14	37	36	35	44	40	43	41	65	58	54	50	54	46	37	59	49	38	93	170	154	134	126	356	326	369
Current Assets	22	18	13	14	15	16	15	14	11	8.5	7.9	6.6	7.3	11	14	36	35	34	42	39	41	36	60	53	48	43	47	39	30	51	41	31	86	163	146	124	101	323	283	242
Cash	21	16	2.8	8.3	8.9	6.1	7.2	6.3	4.4	4.3	7.2	5.9	6.8	3.9	13	36	35	33	42	38	41	35	58	16	8.4	9.6	11	9.8	9.0	15	6.2	11	68	11	29	23	20	288	105	21
Cash & Short-Term Investments	21	16	12	12	14	14	13	12	10	7.3	7.2	5.9	6.8	9.9	13	36	35	33	42	38	41	35	58	51	47	41	45	38	29	39	40	29	85	152	145	123	99	318	279	238
Receivables	1.2	0.2	0.2	0.3	0.5	0.3	0.3	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	–	–	0.2	0.4	0.4	0.5	0.5	0.5	0.5	0.5	0.5	10	0.4	0.4	0.4	10	0.1	0.1	0.1	0.1	0.0	–
Inventory	0.6	1.3	1.1	0.8	0.6	-0.8	-0.8	0.5	0.4	0.3	–	0.0	-0.2	-0.7	–	-0.3	0.0	-0.1	–	–	–	0.0	–	0.0	–	0.0	0.0	37,756	–	0.0	–	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.5	0.6	0.6	0.5	0.5	0.5	0.4	0.4	0.5	0.6	0.9	0.8	1.1	1.5	4.6	5.0	5.2	3.6	4.6	4.8	4.8	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-71	0.0	–	–	–	-17	-6.5	-5.4	-4.3	–	–	-1.1	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	1.7	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	1.1	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	24	23	21	21	20	5.0	4.9	4.7	5.3	4.6	4.9	4.9	4.3	4.3	4.7	5.5	5.8	6.4	7.2	6.5	6.4	10.0	40	39	39	38	48	43	39	36	31	27	25	25	26	29	43	50	48	123
Current Liabilities	6.7	4.9	3.3	17	17	1.7	1.5	1.3	1.9	1.3	1.5	1.6	1.0	0.9	1.3	1.9	2.3	3.0	3.8	3.2	3.0	4.1	14	20	23	24	37	35	33	31	26	22	20	21	22	28	28	36	34	33
Short-Term Debt	0.7	14	14	14	14	–	–	–	–	–	–	–	–	–	–	0.1	0.2	0.2	0.3	0.0	0.0	0.4	0.5	0.6	0.7	0.7	0.7	0.7	0.7	0.7	0.8	0.8	0.8	0.8	0.8	4.2	3.5	3.6	7.2	1.5
Accounts Payable	3.9	3.0	2.5	2.2	1.3	1.7	1.5	1.3	1.9	1.3	1.5	1.5	1.0	0.9	1.3	1.8	2.1	2.7	3.5	3.2	3.0	3.1	4.1	3.1	3.9	4.8	5.4	5.1	6.8	6.2	6.2	6.2	6.5	3.3	5.3	4.8	2.7	1.7	3.9	3.1
Long-Term Debt	17	17	17	0.0	0.0	3.4	3.4	3.4	3.4	3.4	3.4	3.4	3.4	3.4	3.4	3.6	3.5	0.1	3.4	3.4	–	3.4	–	3.4	3.4	3.4	3.4	3.4	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	0.0	-4.0	-7.2	-6.6	-4.3	11	11	9.6	7.0	4.6	3.7	2.4	3.6	6.8	9.6	32	30	28	36	33	37	31	25	19	15	12	6.2	2.7	-1.8	23	18	12	68	145	128	105	84	306	279	246
Retained Earnings	-49	-54	-58	-61	-64	-52	-55	-59	-63	-67	-69	-71	-73	-74	-76	-80	-84	-88	-93	-98	-102	-108	-116	-123	-129	-137	-145	-152	-159	-159	-169	-180	-193	-200	-224	-250	-275	-305	-339	-380
Shares Outstanding	1.8	2.1	2.1	2.2	2.3	2.9	2.7	2.9	3.1	3.1	3.3	3.5	3.7	4.3	6.9	15	20	20	22	23	23	24	24	24	24	25	25	25	26	27	31	32	33	35	46	46	46	49	57	58

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings